Literature DB >> 10749667

Expression and characterization of a recombinant cysteine proteinase of Leishmania mexicana.

S J Sanderson1, K G Pollock, J D Hilley, M Meldal, P S Hilaire, M A Juliano, L Juliano, J C Mottram, G H Coombs.   

Abstract

A major cysteine proteinase (CPB) of Leishmania mexicana, that is predominantly expressed in the form of the parasite that causes disease in mammals, has been overexpressed in Escherichia coli and purified from inclusion bodies to apparent homogeneity. The CPB enzyme, CPB2.8, was expressed as an inactive pro-form lacking the characteristic C-terminal extension (CPB2.8DeltaCTE). Pro-region processing was initiated during protein refolding and proceeded through several intermediate stages. Maximum enzyme activity accompanied removal of the entire pro-region. This was facilitated by acidification. Purified mature enzyme gave a single band on SDS/PAGE and gelatin SDS/PAGE gels, co-migrated with native enzyme in L. mexicana lysates, and had the same N-terminal sequence as the native enzyme. The procedure yielded >3.5 mg of active enzyme per litre of E. coli culture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749667      PMCID: PMC1220970          DOI: 10.1042/0264-6021:3470383

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  Characterisation of three groups of cysteine proteinases in the amastigotes of Leishmania mexicana mexicana.

Authors:  C D Robertson; G H Coombs
Journal:  Mol Biochem Parasitol       Date:  1990 Sep-Oct       Impact factor: 1.759

2.  Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis.

Authors:  A Trabandt; W K Aicher; R E Gay; V P Sukhatme; M Nilson-Hamilton; R T Hamilton; J R McGhee; H G Fassbender; S Gay
Journal:  Matrix       Date:  1990-12

3.  A cysteine proteinase cDNA from Trypanosoma brucei predicts an enzyme with an unusual C-terminal extension.

Authors:  J C Mottram; M J North; J D Barry; G H Coombs
Journal:  FEBS Lett       Date:  1989-12-04       Impact factor: 4.124

4.  Cysteine protease inhibitors as chemotherapy: lessons from a parasite target.

Authors:  P M Selzer; S Pingel; I Hsieh; B Ugele; V J Chan; J C Engel; M Bogyo; D G Russell; J A Sakanari; J H McKerrow
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells.

Authors:  S Yagel; A H Warner; H N Nellans; P K Lala; C Waghorne; D T Denhardt
Journal:  Cancer Res       Date:  1989-07-01       Impact factor: 12.701

7.  Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes.

Authors:  P Matsudaira
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

8.  Isolation and sequence of a cDNA for human pro-(cathepsin L).

Authors:  S Gal; M M Gottesman
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

9.  Activity and deletion analysis of recombinant human cathepsin L expressed in Escherichia coli.

Authors:  S M Smith; M M Gottesman
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

10.  Expression and deletion analysis of the Trypanosoma brucei rhodesiense cysteine protease in Escherichia coli.

Authors:  E G Pamer; C E Davis; M So
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

View more
  12 in total

1.  Identification of lead compounds targeting the cathepsin B-like enzyme of Eimeria tenella.

Authors:  Marie Schaeffer; Joerg Schroeder; Anja R Heckeroth; Sandra Noack; Michael Gassel; Jeremy C Mottram; Paul M Selzer; Graham H Coombs
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Regulated degradation of an endoplasmic reticulum membrane protein in a tubular lysosome in Leishmania mexicana.

Authors:  K A Mullin; B J Foth; S C Ilgoutz; J M Callaghan; J L Zawadzki; G I McFadden; M J McConville
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

3.  α-ketoheterocycles as inhibitors of Leishmania mexicana cysteine protease CPB.

Authors:  Koen Steert; Maya Berg; Jeremy C Mottram; Gareth D Westrop; Graham H Coombs; Paul Cos; Louis Maes; Jurgen Joossens; Pieter Van der Veken; Achiel Haemers; Koen Augustyns
Journal:  ChemMedChem       Date:  2010-10-04       Impact factor: 3.466

4.  Efficient co-expression of a recombinant staphopain A and its inhibitor staphostatin A in Escherichia coli.

Authors:  Benedykt Wladyka; Katarzyna Puzia; Adam Dubin
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

5.  Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.

Authors:  Caroline Schad; Ulrike Baum; Benjamin Frank; Uwe Dietzel; Felix Mattern; Carlos Gomes; Alicia Ponte-Sucre; Heidrun Moll; Uta Schurigt; Tanja Schirmeister
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

6.  Identification and characteristics of a cathepsin L-like cysteine protease from Clonorchis sinensis.

Authors:  Changling Ma; Kai Liang; Lili Tang; Shanshan He; Xiaoquan Liu; Mian He; Yanwen Li
Journal:  Parasitol Res       Date:  2019-01-28       Impact factor: 2.289

7.  Use of recombinant Entamoeba histolytica cysteine proteinase 1 to identify a potent inhibitor of amebic invasion in a human colonic model.

Authors:  Samuel G Meléndez-López; Scott Herdman; Ken Hirata; Min-Ho Choi; Youngchool Choe; Charles Craik; Conor R Caffrey; Elisabeth Hansell; Bibiana Chávez-Munguía; Yen Ting Chen; William R Roush; James McKerrow; Lars Eckmann; Jianhua Guo; Samuel L Stanley; Sharon L Reed
Journal:  Eukaryot Cell       Date:  2007-05-18

8.  Identification and characterization of a cathepsin-L-like peptidase in Eimeria tenella.

Authors:  Renqiang Liu; Xueting Ma; Aijun Liu; Lei Zhang; Jianping Cai; Ming Wang
Journal:  Parasitol Res       Date:  2014-09-25       Impact factor: 2.289

9.  The structure of Leishmania mexicana ICP provides evidence for convergent evolution of cysteine peptidase inhibitors.

Authors:  Brian O Smith; Nichola C Picken; Gareth D Westrop; Krystyna Bromek; Jeremy C Mottram; Graham H Coombs
Journal:  J Biol Chem       Date:  2005-12-28       Impact factor: 5.157

10.  Identification of semicarbazones, thiosemicarbazones and triazine nitriles as inhibitors of Leishmania mexicana cysteine protease CPB.

Authors:  Jörg Schröder; Sandra Noack; Richard J Marhöfer; Jeremy C Mottram; Graham H Coombs; Paul M Selzer
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.